Drreddys Laboratories | RDY - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Aurora Cannabis CAD 536.36M 30.74M 2025-12
Bayer EUR 28.85B 2.9B 2026-03
Canopy Growth CAD 758.17M 22.16M 2025-12
Cipla INR 344.32B 15.13B 2026-03
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Drreddys Laboratories INR 4.14B 107.72M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Pacira USD 653.89M 39.22M 2026-03
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.89B 58.06M 2026-03
Richter Gedeon HUF 1.46T 59.22B 2026-03
Sun Pharmaceuticals INR 835.7B 57.5B 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03